Preview

Альманах клинической медицины

Расширенный поиск
  • image01 Table 1
  • Table 1. Matrix metalloproteinases-2, 7, 8, 9 and their type 1 tissue inhibitor levels (ng/mL) in the serum of renal cancer patients and of the control group patients
  • image02 Fig.
  • ROC curve for evaluation of diagnostic characteristic of the serum MMP 7 levels for comparison of renal cancer patients and the control group
  • image03 Table 2
  • Table 2. Matrix metalloproteinases-2, 7, 8, 9 and their type 1 tissue inhibitor levels (ng/mL) in the serum of renal cancer patients depending on the tumor spread
  • image04 Table 3
  • Table 3. Matrix metalloproteinases-2, 7, 8, 9 and their type 1 tissue inhibitor levels (ng/mL) in the serum of renal cancer patients depending on histological characteristics and differentiation of the tumor

Для цитирования:


Герштейн Е.С., Муштенко В.В., Короткова Е.А., Бежанова С.Д., Морозов А.А., Алферов А.А., Казанцева И.А., Кушлинский Н.Е. Матриксные металлопротеиназы-2, 7, 8, 9 и их тканевой ингибитор 1-го типа в сыворотке крови больных раком почки: клинико-морфологические корреляции. Альманах клинической медицины. 2017;45(2):94-101. https://doi.org/10.18786/2072-0505-2017-45-2-94-101

For citation:


Gershtein E.S., Mushtenko V.V., Korotkova E.A., Bezhanova S.D., Morozov A.A., Alferov A.A., Kazantseva I.A., Kushlinskii N.E. Matrix metalloproteinases 2, 7, 8, 9 and their type 1 tissue inhibitor in serum of renal cancer patients: clinical and pathologic correlations. Almanac of Clinical Medicine. 2017;45(2):94-101. (In Russ.) https://doi.org/10.18786/2072-0505-2017-45-2-94-101

Просмотров: 4146


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2072-0505 (Print)
ISSN 2587-9294 (Online)